VEGFA and neoplasm: Bevacizumab targets vascular endothelial growth factor A (VEGFA), a protein expressed in a variety of tumors including EAC stimulating the formation of new blood vessels, which are essential for the supply of nutrients and oxygen to the tumor [43,44].